Treatment of patent ductus arteriosus (PDA) using ibuprofen: Renal side-effects in VLBW and ELBW newborns

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 26, Issue 4, 2013, Pages 423-429

  Bagnoli, Franco ^a   Rossetti, Annalisa ^a   Messina, Gabriele ^a   Mori, Annalisa ^a   Casucci, Martina ^a   Tomasini, Barbara ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

ELBW; Ibuprofen; Newborn; Patent ductus arteriosus; PDA; Renal failure; VLBW

Indexed keywords

CREATININE; IBUPROFEN; NITROGEN; PLACEBO; UREA;

ARTICLE; BIRTH WEIGHT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DOUBLE BLIND PROCEDURE; DRUG DOSE COMPARISON; DRUG SAFETY; EXTREMELY LOW BIRTH WEIGHT; FEMALE; GESTATIONAL AGE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY DISEASE; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NEWBORN; PARALLEL DESIGN; PATENT DUCTUS ARTERIOSUS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; UREA NITROGEN BLOOD LEVEL; VERY LOW BIRTH WEIGHT;

BIRTH WEIGHT; BLOOD UREA NITROGEN; CREATININE; CYCLOOXYGENASE INHIBITORS; DUCTUS ARTERIOSUS, PATENT; FEMALE; GESTATIONAL AGE; GLOMERULAR FILTRATION RATE; HUMANS; IBUPROFEN; INFANT, EXTREMELY LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; INFANT, VERY LOW BIRTH WEIGHT; KIDNEY DISEASES; MALE; PLACEBOS; RISK FACTORS;

EID: 84873427525     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2012.733775     Document Type: Article

References (31)

1. Rubaltelli FF, Dani C, Reali MF, Bertini G, Wiechmann L, Tangucci M, Spagnolo A. Acute neonatal respiratory distress in Italy: A one-year prospective study. Italian Group of Neonatal Pneumology. Acta Paediatr 1998;87:1261-1268
2. Gonzalez A, Sosenko IR, Chandar J, Hummler H, Claure N, Bancalari E. Influence of infection on patent ductus arteriosus and chronic lung disease in premature infants weighing 1000 grams or less. J Pediatr 1996;128:470-478
3. Corff KE, Sekar KC. Clinical considerations for the pharmacological management of patent ductus arteriosus with cyclooxygenase inhibitors in premature infants. J Pediatr Pharmacol Ther 2007;12:147-157
4. Mercanti I, Boubred F, Simeoni U. Therapeutic closure of the ductus arteriosus: Benefits and limitations. J Matern Fetal Neonatal Med 2009;22 SUPPL3:14-20
5. Van Overmeire B, Smets K, Lecoutere D, Van de Broek H, Weyler J, Degroote K, Langhendries JP. A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus. N Engl J Med 2000;343:674-681
6. Varvarigou A, Bardin CL, Beharry K, Chemtob S, Papageorgiou A, Aranda JV. Early ibuprofen administration to prevent patent ductus arteriosus in premature newborn infants. JAMA 1996;275:539-544
7. Van Overmeire B, Follens I, Hartmann S, Creten WL, Van Acker KJ. Treatment of patent ductus arteriosus with ibuprofen. Arch Dis Child Fetal Neonatal Ed 1997;76:F179-F184
8. Ohlsson A, Walia R, Shah S. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev 2008;CD003481
9. Mosca F, Bray M, Lattanzio M, Fumagalli M, Tosetto C. Comparative evaluation of the effects of indomethacin and ibuprofen on cerebral perfusion and oxygenation in preterm infants with patent ductus arteriosus. J Pediatr 1997;131:549-554
10. Patel J, Roberts I, Azzopardi D, Hamilton P, Edwards AD. Randomized double-blind controlled trial comparing the effects of ibuprofen with indomethacin on cerebral hemodynamics in preterm infants with patent ductus arteriosus. Pediatr Res 2000;47:36-42
11. Pezzati M, Vangi V, Biagiotti R, Bertini G, Cianciulli D, Rubaltelli FF. Effects of indomethacin and ibuprofen on mesenteric and renal blood flow in preterm infants with patent ductus arteriosus. J Pediatr 1999;135:733-738
12. Dani C, Bertini G, Pezzati M, Poggi C, Guerrini P, Martano C, Rubaltelli FF; IntraVentricular Ibuprofen Study Group. Prophylactic ibuprofen for the prevention of intraventricular hemorrhage among preterm infants: A multicenter, randomized study. Pediatrics 2005;115:1529-1535
13. Antonucci R, Cuzzolin L, Arceri A, DessA, Fanos V. Changes in urinary PGE2 after ibuprofen treatment in preterm infants with patent ductus arteriosus. Eur J Clin Pharmacol 2009;65:223-230
14. Cuzzolin L, Fanos V, Pinna B, di Marzio M, Perin M, Tramontozzi P, Tonetto P, Cataldi L. Postnatal renal function in preterm newborns: A role of diseases, drugs and therapeutic interventions. Pediatr Nephrol 2006;21:931-938
15. Vieux R, Desandes R, Boubred F, Semama D, Guillemin F, Buchweiller MC, Fresson J, Hascoet JM. Ibuprofen in very preterm infants impairs renal function for the first month of life. Pediatr Nephrol 2010;25:267-274
16. Schwartz GJ, Brion LP, Spitzer A. The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin North Am 1987;34:571-590
17. Practical Statistics for Medical Research, Douglas G. Altman. ISBN 10: 0412276305 / 0-412-27630-5. ISBN 13: 9780412276309. Chapman & Hall; 1991. Binding: Hardcover
18. Lago P, Bettiol T, Salvadori S, Pitassi I, Vianello A, Chiandetti L, Saia OS. Safety and efficacy of ibuprofen versus indomethacin in preterm infants treated for patent ductus arteriosus: A randomised controlled trial. Eur J Pediatr 2002;161:202-207
19. Allegaert K. The impact of ibuprofen or indomethacin on renal drug clearance in neonates. J Matern-Fetal Neonatal Med 2009;22:88-91
20. Speziale MV, Allen RG, Henderson CR, Barrington KJ, Finer NN. Effects of ibuprofen and indomethacin on the regional circulation in newborn piglets. Biol Neonate 1999;76:242-252
21. Katakam LI, Cotten CM, Goldberg RN, Dang CN, Smith PB. Safety and effectiveness of indomethacin versus ibuprofen for treatment of patent ductus arteriosus. Am J Perinatol 2010;27:425-429
22. Aranda JV, Clyman R, Cox B, Van Overmeire B, Wozniak P, Sosenko I, Carlo WA, et al. A randomized, double-blind, placebocontrolled trial on intravenous ibuprofen L-lysine for the early closure of nonsymptomatic patent ductus arteriosus within 72 hours of birth in extremely low-birth-weight infants. Am J Perinatol 2009;26:235-245
23. Van Overmeire B, Allegaert K, Casaer A, Debauche C, DecaluwW, Jespers A, Weyler J, et al. Prophylactic ibuprofen in premature infants: A multicentre, randomised, double-blind, placebo-controlled trial. Lancet 2004;364:1945-1949
24. Fanos V, Benini D, Verlato G, Errico G, Cuzzolin L. Efficacy and renal tolerability of ibuprofen vs. indomethacin in preterm infants with patent ductus arteriosus. Fundam Clin Pharmacol 2005;19:187-193
25. Gournay V, Roze JC, Kuster A, Daoud P, Cambonie G, Hascoet JM, Chamboux C, et al. Prophylactic ibuprofen versus placebo in very premature infants: A randomised, double-blind, placebo-controlled trial. Lancet 2004;364:1939-1944
26. Antonucci R, Fanos V. NSAIDs, prostaglandins and the neonatal kidney. J Matern Fetal Neonatal Med 2009;22 SUPPL3:23-26
27. Cuzzolin L, Dal CerM, Fanos V. NSAID-induced nephrotoxicity from the fetus to the child. Drug Saf 2001;24:9-18
28. Giniger RP, Buffat C, Millet V, Simeoni U. Renal effects of ibuprofen for the treatment of patent ductus arteriosus in premature infants. J Matern Fetal Neonatal Med 2007;20:275-283
29. Allegaert K, Rayyan M, Anderson BJ. Impact of ibuprofen administration on renal drug clearance in the first weeks of life. Methods Find Exp Clin Pharmacol 2006;28:519-522
30. Allegaert K, Vanhole C, de Hoon J, Guignard JP, Tibboel D, Devlieger H, Van Overmeire B. Nonselective cyclo-oxygenase inhibitors and glomerular filtration rate in preterm neonates. Pediatr Nephrol 2005;20:1557-1561
31. Li Y, Zelenina M, Plat-Willson G, Marcoux MO, Aperia A, Casper C. Urinary aquaporin-2 excretion during ibuprofen or indomethacin treatment in preterm infants with patent ductus arteriosus. Acta Paediatr 2011;100:59-66